Considering previously reported known POLE or POLD1 mutation carriers, the phenotypic spectrum included multiple polyps and early-onset CRC, as well as family history and would reinforce therefore the phenotype selection criteria used in our cohort. This evidence concerns the gene POLE and colorectal carcinoma.